Literature DB >> 18662155

[Thrombocytopenia in a patient on peritoneal dialysis].

B Ortín Pascual1, M A Salgueró Solis, V Bodi Ramos, I García Juan, I Maicas Torregrosa, R Ramón García, A Miguel Carrasco.   

Abstract

Adverse reactions to drugs occur in up to 6% of hospitalized patients and are an important cause of increment in morbimortality. The widely-prescribed antibiotics beta-lactams and sulfamides are the most frequently associated to adverse reactions and hypersensitivity. Vancomycin is a glycopeptidic antibiotic used to treat infections caused by Staph. coagulasa positive (S. aureus) and Staph. coagulasa negative. Nowadays its extensive use is a consequence of bacterial resistance to classical antibiotics such as beta-lactams. In Nephrology Units, vancomycin is the antibiotic of first choice to treat staphylococcal infections related to central venous catheters for hemodialysis, as well as for the treatment of peritonitis in patients undergoing peritoneal dialysis. Toxicity due to vancomycin includes the "red man syndrome", ototoxicity and hematological toxicity. The most common sign of haematological toxicity is mild neutropenia; less frecuent are leukocytosis, eosinophilia, agranulocytosis and thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662155

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  2 in total

Review 1.  Vancomycin-Induced Thrombocytopenia: A Narrative Review.

Authors:  Mehdi Mohammadi; Zahra Jahangard-Rafsanjani; Amir Sarayani; Molouk Hadjibabaei; Maryam Taghizadeh-Ghehi
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

2.  Vancomycin Induced Thrombocytopenia - Protracted Course in a Hemodialysis Patient.

Authors:  Nisha Elizabeth Ajit; Sindhu Priya Devarashetty; Samip Master
Journal:  Case Rep Oncol       Date:  2019-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.